Pre-Submission Review for Cardiovascular Research: What Circulation and JACC Reviewers Expect
Cardiovascular manuscripts face specific scrutiny on clinical endpoints, statistical rigor, and Clinical Perspective sections. Here is what Circulation, JACC, and European Heart Journal reviewers expect.
Assistant Professor, Cardiovascular & Metabolic Disease
Author context
Works across cardiovascular biology and metabolic disease, with expertise in navigating high-impact journal submission requirements for Circulation, JACC, and European Heart Journal.
Readiness scan
Find out if this manuscript is ready to submit.
Run the Free Readiness Scan before you submit. Catch the issues editors reject on first read.
How to use this page well
These pages work best when they behave like tools, not essays. Use the quick structure first, then apply it to the exact journal and manuscript situation.
Question | What to do |
|---|---|
Use this page for | Building a point-by-point response that is easy for reviewers and editors to trust. |
Start with | State the reviewer concern clearly, then pair each response with the exact evidence or revision. |
Common mistake | Sounding defensive or abstract instead of specific about what changed. |
Best next step | Turn the response into a visible checklist or matrix before you finalize the letter. |
Decision cue: Cardiovascular research is one of the highest-stakes publishing fields. Circulation desk rejects 60 to 70% of submissions. JACC desk rejects about 60%. European Heart Journal about 50%. All three journals send papers for independent statistical review, which means your analytical methods face scrutiny from dedicated statisticians, not just clinical reviewers. The Clinical Perspective box (required at Circulation and JACC) is one of the first things editors read and directly influences the triage decision.
Check your cardiovascular manuscript readiness in 60 seconds with the free scan.
What makes cardiovascular manuscripts uniquely challenging
Independent statistical review at every top journal
Circulation, JACC, and European Heart Journal all send manuscripts for independent statistical review in addition to clinical peer review. This dual-track review means your statistical methods will be evaluated by someone whose primary expertise is biostatistics, not cardiology. They check:
- sample size calculations and power analysis
- appropriateness of the primary analysis (intention-to-treat vs per-protocol)
- handling of missing data (multiple imputation, sensitivity analyses)
- multiplicity corrections for secondary endpoints and subgroup analyses
- time-to-event analysis methodology (Kaplan-Meier, Cox proportional hazards)
- competing risk analysis where applicable
- effect size reporting with confidence intervals
The Clinical Perspective requirement
Circulation requires a Clinical Perspective section with two questions answered in bulleted format:
"What Is New?" (maximum 100 words, 2 to 3 bullets) - What the paper adds to existing knowledge.
"What Are the Clinical Implications?" (maximum 100 words, 2 to 3 bullets) - How the findings affect clinical practice.
JACC requires a Central Illustration and a similar clinical significance framing. European Heart Journal has its own Translational Outlook requirement.
These sections are not afterthoughts. Editors read them before deciding on triage. A weak Clinical Perspective signals that the clinical consequence is unclear, which is exactly what triggers desk rejection.
Cardiovascular clinical trial standards
Cardiovascular trials have some of the most rigorous reporting requirements in medicine:
- CONSORT 2025 compliance (with the new statistical analysis plan transparency requirements)
- DSMB oversight documentation
- pre-specified stopping rules
- adjudicated clinical endpoints (not self-reported)
- appropriate comparators (not just placebo vs active when standard of care exists)
The cardiovascular pre-submission checklist
For clinical trials
- CONSORT 2025 checklist complete with page references
- primary endpoint matches registration (ClinicalTrials.gov)
- DSMB charter and stopping rules described
- endpoints adjudicated by blinded committee
- appropriate comparator selected and justified
- patient-reported outcomes included
- long-term follow-up data or plan described
- cost-effectiveness or health economic data if applicable
For observational studies
- STROBE checklist complete
- confounding addressed systematically (propensity score, instrumental variables, or other approach)
- sensitivity analyses for unmeasured confounding
- temporal relationships established where causal claims are made
- large enough sample for the effect size claimed
For basic/translational cardiovascular research
- relevance to human cardiovascular disease explicitly stated
- multiple experimental models used
- in vivo validation of in vitro findings
- translational pathway described (mechanism to therapeutic target)
- appropriate heart failure models, arrhythmia models, or atherosclerosis models used
Clinical Perspective and framing
- Clinical Perspective box completed (Circulation format: 2 to 3 bullets for each question, 100 words each maximum)
- Central Illustration prepared (JACC)
- clinical implication stated concretely, not speculatively
- the finding represents a genuine change in clinical thinking or practice
Where pre-submission review helps most in cardiovascular research
The Manusights free readiness scan evaluates methodology, citation integrity, and journal fit in about 60 seconds. For cardiovascular manuscripts, citation verification is particularly important because the field publishes landmark trials frequently and missing a recent trial that changed practice signals an incomplete literature review.
The $29 AI Diagnostic provides figure-level feedback, which matters for cardiovascular papers that rely on Kaplan-Meier curves, forest plots, and waterfall plots to communicate results. Figure-text inconsistencies in these critical displays undermine credibility.
For manuscripts targeting Circulation, JACC, or European Heart Journal, Manusights Expert Review ($1,000 to $1,800) connects you with cardiovascular reviewers who have published in and reviewed for these journals.
How top cardiovascular journals compare
Feature | JACC | European Heart Journal | Circulation Research | |
|---|---|---|---|---|
Scope | Broad cardiovascular clinical | Clinical cardiology | Broad cardiovascular (European) | Basic/translational |
Desk rejection | 60 to 70% | ~60% | ~50% | ~40% |
First decision | ~17 days | ~14 days | ~21 days | ~30 days |
Statistical review | Independent | Independent | Independent | Yes |
Special section | Clinical Perspective | Central Illustration | Translational Outlook | N/A |
Best for | Practice-changing cardiovascular | Interventional + clinical | European/global cardiovascular | Mechanistic cardiovascular |
Sources
On this page
Reference library
Use the core publishing datasets alongside this guide
This article answers one part of the publishing decision. The reference library covers the recurring questions that usually come next: how selective journals are, how long review takes, and what the submission requirements look like across journals.
Dataset / reference guide
Peer Review Timelines by Journal
Reference-grade journal timeline data that authors, labs, and writing centers can cite when discussing realistic review timing.
Dataset / benchmark
Biomedical Journal Acceptance Rates
A field-organized acceptance-rate guide that works as a neutral benchmark when authors are deciding how selective to target.
Reference table
Journal Submission Specs
A high-utility submission table covering word limits, figure caps, reference limits, and formatting expectations.
Final step
Find out if this manuscript is ready to submit.
Run the Free Readiness Scan. See score, top issues, and journal-fit signals before you submit.
Anthropic Privacy Partner. Zero-retention manuscript processing.
Need deeper scientific feedback? See Expert Review Options
Where to go next
Start here
Same journal, next question
Supporting reads
Conversion step
Find out if this manuscript is ready to submit.
Anthropic Privacy Partner. Zero-retention manuscript processing.